Effect of immigration on multiple sclerosis sex ratio in Canada: The Canadian Collaborative Study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 1, 2010, Pages 31-36

  Orton, S M ^a   Ramagopalan, S V ^a   Brocklebank, D ^a   Herrera, B M ^a   Dyment, D A ^a   Yee, I M ^b   Sadovnick, A D ^b   Ebers, G C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; IMMIGRATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL; SEX RATIO; SOUTHERN EUROPE;

ADULT; AGE FACTORS; AGE OF ONSET; CANADA; EMIGRATION AND IMMIGRATION; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; PREVALENCE; REGRESSION ANALYSIS; SEX FACTORS; SEX RATIO; TIME FACTORS;

EID: 73449095443     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.162784     Document Type: Article

References (40)

1. Larsen JP, Kvaale G, Riise T, et al. An increase in the incidence of multiple sclerosis in western Norway. Acta Neurol Scand 1984;70:96-103.
2. Phadke JG, Downie AW. Epidemiology of multiple sclerosis in the north-east (Grampian region) of Scotland - an update. J Epidemiol Community Health 1987;41:5-13.
3. McLeod JG, Hammond SR, Hallpike JF. Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results. Med J Aust 1994;160:117-22.
4. Koch-Henriksen N. The Danish Multiple Sclerosis Registry: a 50-year follow-up. Mult Scler 1999;5:293-6.
5. Pugliatti M, Sotgiu S, Solinas G, et al. Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk. Acta Neurol Scand 2001;103:20-6.
6. Noonan CW, Kathman SJ, White MC. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 2002;58:136-8.
7. Barnett MH, Williams DB, Day S, et al. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. J Neurol Sci 2003;213:1-6.
8. Wallin MT, Page WF, Kurtzke JF. Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography. Ann Neurol 2004;55:65-71.
9. Nicoletti A, Patti F, Lo Fermo S, et al. Possible increasing risk of multiple sclerosis in Catania, Sicily. Neurology 2005;65:1259-63.
10. Grytten N, Glad SB, Aarseth JH, et al. A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. Neurology 2006;66:182-6.
11. Debouverie M, Pittion-Vouyovitch S, Louis S, et al. Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France. Mult Scler 2007;13:962-7.
12. Granieri E, Economou NT, De Gennaro R, et al. Multiple sclerosis in the province of Ferrara: evidence for an increasing trend. J Neurol 2007;254:1642-8.
13. Hirst C, Ingram G, Pickersgill T, et al. Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 2009;80:386-91.
14. Orton SM, Herrera BM, Yee IM, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006;5:932-6.
15. Grimaldi LM, Salemi G, Grimaldi G, et al. High incidence and increasing prevalence of MS in Enna (Sicily), southern Italy. Neurology 2001;57:1891-3.
16. Ford HL, Gerry E, Airey CM, et al. The prevalence of multiple sclerosis in the Leeds Health Authority. J Neurol Neurosurg Psychiatry 1998;64:605-10.
17. McDonnell GV, Hawkins SA. An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology 1998;50:423-8.
18. Robertson N, Deans J, Fraser M, et al. Multiple sclerosis in the north Cambridgeshire districts of East Anglia. J Neurol Neurosurg Psychiatry 1995;59:71-6.
19. Rothwell PM, Charlton D. High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatry 1998;64:730-5.
20. Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008;71:129-35.
21. Kurtzke JF, Beebe GW, Norman JE Jr. Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS. Neurology 1985;35:672-8.
22. Dean G, Kurtzke JF. On the risk of multiple sclerosis according to age at immigration to South Africa. BMJ 1971;3:725-9.
23. Dean G, Elian M. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63:565-8.
24. Pugliatti M, Riise T, Sotgiu MA, et al. Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in a Sardinian population. Am J Epidemiol 2006;164:326- 33.
25. Sadovnick AD, Risch NJ, Ebers GC. Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group. Can J Neurol Sci 1998;25:216-21.
26. Statistics Canada S. StatsCan Census Data, 2001.
27. Anon. R: A language and environment for statistical computing [program]. Vienna: Foundation for Statistical Computing, 2004.
28. Beck CA, Metz LM, Svenson LW, et al. Regional variation of multiple sclerosis prevalence in Canada. Mult Scler 2005;11:516- 19.
29. Ranzato F, Perini P, Tzintzeva E, et al. Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey. Mult Scler 2003;9:387-92.
30. Modrego PJ, Pina MA. Trends in prevalence and incidence of multiple sclerosis in Bajo Aragon, Spain. J Neurol Sci 2003;216:89-93.
31. Compston A, Lassmann H, Wekerle H, et al. McAlpine's multiple sclerosis, 4th edn. Philadelphia: Churchill livingstone, Elsevier, 2005.
32. Pugliatti M, Rosati G, Carton H, et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 2006;13:700-22.
33. Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002;104:182-91.
34. Al-Din AS. Multiple sclerosis in Kuwait: clinical and epidemiological study. J Neurol Neurosurg Psychiatry 1986;49:928- 31.
35. Al-Araji A, Mohammed AI. Multiple sclerosis in Iraq: does it have the same features encountered in Western countries? J Neurol Sci 2005;234:67-71.
36. Ramagopalan SV, Dyment DA, Ebers GC. Genetic epidemiology: the use of old and new tools for multiple sclerosis. Trends Neurosci 2008;31:645-52.
37. Chao MJ, Ramagopalan SV, Herrera BM, et al. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. Hum Mol Genet 2009;18:261-6.
38. Giovannoni G, Ebers G. Multiple sclerosis: the environment and causation. Curr Opin Neurol 2007;20:261-8.
39. Pugliatti M, Harbo HF, Holmoy T, et al. Environmental risk factors in multiple sclerosis. Acta Neurol Scand Suppl 2008;188:34-40.
40. Kurtzke JF. Multiple sclerosis in time and space - geographic clues to cause. J Neurovirol 2000;6(2 Suppl):S134-40.